Evidence map›Paper›PMID 39076611›Full record

ArticleResearch in diagnostic and interventional imaging2022

Prediction model for patient prognosis in idiopathic pulmonary fibrosis using hybrid radiomics analysis.

Daisuke Kawahara, Takeshi Masuda, Riku Nishioka, Masashi Namba, Nobuki Imano, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Shintaro Miyamoto, Taku Nakashima and 6 more

Abstract read
In one paragraph

Article in Research in diagnostic and interventional imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Cuproptosis-related geneBiomolecules & biomedicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Daisuke KawaharaDepartment of Radiation Oncology, Graduate School of Biomedical Health Sciences, Hiroshima University, 1-3-2 Kagamiyama, Hiroshima 734-8551, Japan.
Takeshi MasudaDepartment of Respiratory Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Riku NishiokaDepartment of Radiation Oncology, Graduate School of Biomedical Health Sciences, Hiroshima University, 1-3-2 Kagamiyama, Hiroshima 734-8551, Japan.
Masashi NambaDepartment of Clinical Oncology, Hiroshima University Hospital, Hiroshima, Japan.
Nobuki ImanoDepartment of Radiation Oncology, Graduate School of Biomedical Health Sciences, Hiroshima University, 1-3-2 Kagamiyama, Hiroshima 734-8551, Japan.
Kakuhiro YamaguchiDepartment of Respiratory Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Shinjiro SakamotoDepartment of Respiratory Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Yasushi HorimasuDepartment of Respiratory Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Shintaro MiyamotoDepartment of Respiratory Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Taku NakashimaDepartment of Respiratory Medicine, Hiroshima University Hospital, Hiroshima, Japan.
Hiroshi IwamotoDepartment Molecular and Internal Medicine, Graduate School of Biomedical Health Sciences, Hiroshima University, Hiroshima, Japan.
Shinichiro OhshimoDepartment of Emergency and Critical Care Medicine, Hiroshima University Hospital, Hiroshima, 734-8551, Japan.
Kazunori FujitakaDepartment Molecular and Internal Medicine, Graduate School of Biomedical Health Sciences, Hiroshima University, Hiroshima, Japan.
Hironobu HamadaDepartment of Physical Analysis and Therapeutic Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Noboru HattoriDepartment Molecular and Internal Medicine, Graduate School of Biomedical Health Sciences, Hiroshima University, Hiroshima, Japan.
Yasushi NagataDepartment of Radiation Oncology, Graduate School of Biomedical Health Sciences, Hiroshima University, 1-3-2 Kagamiyama, Hiroshima 734-8551, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To develop an imaging prognostic model for idiopathic pulmonary fibrosis (IPF) patients using hybrid auto-segmentation radiomics analysis, and compare the predictive ability between the radiomics analysis and conventional visual score methods. Methods: Data from 72 IPF patients who had undergone CT were analyzed. In the radiomics analysis, quantitative CT analysis was performed using the semi-auto-segmentation method. In the visual method, the extent of radiologic abnormalities was evaluated and the overall percentage of lung involvement was calculated by averaging values for six lung zones. Using a training cohort of 50 cases, we generated a radiomics model and a visual score model. Subsequently, we investigated the predictive ability of these models in a testing cohort of 22 cases. Results: Three significant prognostic factors such as contrast, Idn, and cluster shade were selected by LASSO Cox regression analysis. In the visual method, multivariate Cox regression analysis revealed that honeycombing and reticulation were significant prognostic factors. Subsequently, a predictive nomogram for prognosis in IPF patients was established using these factors. In the testing cohort, the c-index of the visual and radiomics nomograms were 0.68 and 0.74, respectively. When dividing the cohort into high-risk and low-risk groups using the median nomogram score, significant differences in overall survival (OS) in the visual and radiomics models were observed (P=0.000 and P=0.0003, respectively). Conclusions: The prediction model with hybrid radiomics analysis had a better ability to predict OS in IPF patients than that of the visual method.

Indexed as

IPFMachine learningRadiomics

Identifiers

PMID39076611
PMCPMC11265392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.